Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2016 (2016), Article ID 8797691, 4 pages
http://dx.doi.org/10.1155/2016/8797691
Case Report

Novel Approach for Enterocutaneous Fistula Treatment with the Use of Viable Cryopreserved Placental Membrane

Macomb Surgical Specialists, PLC, 27472 Schoenherr Road, Suite 150, Warren, MI 48088, USA

Received 15 July 2016; Revised 14 September 2016; Accepted 9 October 2016

Academic Editor: Christophoros Foroulis

Copyright © 2016 Frederick Nichols and Aaron Overly. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Williams, S. Zolfaghari, and R. P. Boushey, “Complications of enterocutaneous fistulas and their management,” Clinics in Colon and Rectal Surgery, vol. 23, no. 3, pp. 209–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-H. Lee, “Surgical management of enterocutaneous fistula,” Korean Journal of Radiology, vol. 13, supplement 1, pp. S17–S20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Taggarshe, D. Bakston, M. Jacobs, A. McKendrick, and V. K. Mittal, “Management of enterocutaneous fistulae: a 10 years experience,” World Journal of Gastrointestal Surgery, vol. 2, no. 7, pp. 242–246, 2010. View at Publisher · View at Google Scholar
  4. J. M. Draus Jr., S. A. Huss, N. J. Harty, W. G. Cheadle, and G. M. Larson, “Enterocutaneous fistula: are treatments improving?” Surgery, vol. 140, no. 4, pp. 570–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Bose, “Burn wound dressing with human amniotic membrane,” Annals of the Royal College of Surgeons of England, vol. 61, no. 6, pp. 444–447, 1979. View at Google Scholar · View at Scopus
  6. M. R. Kesting, K.-D. Wolff, B. Hohlweg-Majert, and L. Steinstraesser, “The role of allogenic amniotic membrane in burn treatment,” Journal of Burn Care and Research, vol. 29, no. 6, pp. 907–916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Gruss and D. W. Jirsch, “Human amniotic membrane: a versatile wound dressing,” Canadian Medical Association Journal, vol. 118, no. 10, pp. 1237–1246, 1978. View at Google Scholar · View at Scopus
  8. W. P. Faulk, P. Stevens, H. Burgos, R. Matthews, J. Bennett, and B.-L. Hsi, “Human amnion as an adjunct in wound healing,” The Lancet, vol. 315, no. 8179, pp. 1156–1158, 1980. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Egan, J. O'Driscoll, and D. R. Thakar, “Human amnion in the management of chronic ulceration of the lower limb: a clinico-pathologic study,” Angiology, vol. 34, no. 3, pp. 197–203, 1983. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Rahman, D. G. Said, V. S. Maharajan, and H. S. Dua, “Amniotic membrane in ophthalmology: indications and limitations,” Eye, vol. 23, no. 10, pp. 1954–1961, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Sham and N. Sultana, “Biological wound dressing—role of amniotic membrane,” International Journal of Dental Clinics, vol. 3, no. 3, pp. 71–72, 2011. View at Google Scholar
  12. S. K. Munoyath, J. Sathishwaran, and K. Prasad, “Efficacy of human amniotic membrane and collagen in maxillofacial soft tissue defects—a comparative clinical study,” Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, vol. 27, no. 6, pp. 786–790, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Zohar, Y. P. Talmi, Y. Finkelstein, Y. Shvili, R. Sadov, and N. Laurian, “Use of human amniotic membrane in otolaryngologic practice,” Laryngoscope, vol. 97, no. 8, pp. 978–980, 1987. View at Google Scholar · View at Scopus
  14. M. Trelford Sauder, J. D. Trelford, and N. M. Matolo, “Replacement of the peritoneum with amnion following pelvic exenteration,” Surgery Gynecology and Obstetrics, vol. 145, no. 5, pp. 699–701, 1977. View at Google Scholar · View at Scopus
  15. L. F. Bleggi-Torres, B. Werner, and M. J. Piazza, “Ultrastructural study of the neovagina following the utilization of human amniotic membrane for treatment of congenital absence of the vagina,” Brazilian Journal of Medical and Biological Research, vol. 30, no. 7, pp. 861–864, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Parolini, F. Alviano, G. P. Bagnara et al., “Concise review: isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta Derived Stem Cells,” Stem Cells, vol. 26, no. 2, pp. 300–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. C. Mamede, M. J. Carvalho, A. M. Abrantes, M. Laranjo, C. J. Maia, and M. F. Botelho, “Amniotic membrane: from structure and functions to clinical applications,” Cell and Tissue Research, vol. 349, no. 2, pp. 447–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Niknejad, H. Peirovi, M. Jorjani, A. Ahmadiani, J. Ghanavi, and A. M. Seifalian, “Properties of the amniotic membrane for potential use in tissue engineering,” European Cells and Materials, vol. 15, pp. 88–99, 2008. View at Google Scholar · View at Scopus
  19. S. Ilancheran, Y. Moodley, and U. Manuelpillai, “Human fetal membranes: a source of stem cells for tissue regeneration and repair?” Placenta, vol. 30, no. 1, pp. 2–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. N. Brantley and T. D. Verla, “Use of placental membranes for the treatment of chronic diabetic foot ulcers,” Advances in Wound Care, vol. 4, no. 9, pp. 545–559, 2015. View at Publisher · View at Google Scholar
  21. V. Lo and E. Pope, “Amniotic membrane use in dermatology,” International Journal of Dermatology, vol. 48, no. 9, pp. 935–940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Banas, C. Trumpower, C. Bentlejewski, V. Marshall, G. Sing, and A. Zeevi, “Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells,” Human Immunology, vol. 69, no. 6, pp. 321–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kubo, Y. Sonoda, R. Muramatsu, and M. Usui, “Immunogenicity of human amniotic membrane in experimental xenotransplantation,” Investigative Ophthalmology & Visual Science, vol. 42, no. 7, pp. 1539–1546, 2001. View at Google Scholar · View at Scopus
  24. G. W. Gibbons, “Grafix®, a cryopreserved placental membrane, for the treatment of chronic/stalled wounds,” Advances in Wound Care, vol. 4, no. 9, pp. 534–544, 2015. View at Publisher · View at Google Scholar
  25. D. T. Price and T. C. Price, “Robotic repair of a vesicovaginal fistula in an irradiated field using a dehydrated amniotic allograft as an interposition patch,” Journal of Robotic Surgery, vol. 10, no. 1, pp. 77–80, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Duan-Arnold, A. Gyurdieva, A. Johnson, T. E. Uveges, D. A. Jacobstein, and A. Danilkovitch, “Retention of endogenous viable cells enhances the anti-inflammatory activity of cryopreserved amnion,” Advances in Wound Care, vol. 4, no. 9, pp. 523–533, 2015. View at Publisher · View at Google Scholar
  27. Y. Duan-Arnold, T. E. Uveges, A. Gyurdieva, A. Johnson, and A. Danilkovitch, “Angiogenic potential of cryopreserved amniotic membrane is enhanced through retention of all tissue components in their native state,” Advances in Wound Care, vol. 4, no. 9, pp. 513–522, 2015. View at Publisher · View at Google Scholar
  28. Y. Duan-Arnold, A. Gyurdieva, A. Johnson, D. A. Jacobstein, and A. Danilkovitch, “Soluble factors released by endogenous viable cells enhance the antioxidant and chemoattractive activities of cryopreserved amniotic membrane,” Advances in Wound Care, vol. 4, no. 6, pp. 329–338, 2015. View at Publisher · View at Google Scholar
  29. M. Regulski, D. A. Jacobstein, R. D. Petrano, V. J. Migliori, G. Nair, and D. A. Pfeiffer, “Retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds,” Ostomy Wound Management, vol. 59, no. 12, pp. 38–43, 2013. View at Google Scholar
  30. L. A. Lavery, J. Fulmer, K. A. Shebetka et al., “The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial,” International Wound Journal, vol. 11, no. 5, pp. 554–560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. G. Frykberg, G. W. Gibbons, J. L. Walters, D. K. Wukich, and F. C. Milstein, “A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane,” International Wound Journal, 2016. View at Publisher · View at Google Scholar
  32. Y. P. Talmi, Y. Finkelstein, and Y. Zohar, “Use of human amniotic membrane as a biologic dressing,” European Journal of Plastic Surgery, vol. 13, no. 4, pp. 160–162, 1990. View at Publisher · View at Google Scholar · View at Scopus